Summary
GLAXOSMITHKLINE has refuted claims that bumper pay awards to non- executive directors will undermine their independence.
The drugs giant reckons it has been underpaying nonexecs and wants to bring salaries up to the industry average, which it says is Pounds 57,000.See the full content of this document
Extract
Now Glaxo Defends Non-Execs' Gravy Train
A spokesman said: 'If you wan...
See the full content of this document
Sponsored links
